Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ABBOTT LABORATORIES ABT

Healthcare Medical Devices
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the... see more

Recent & Breaking News (NYSE:ABT)

Abbott Reports First-Quarter 2014 Results

PR Newswire April 16, 2014

Abbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes

PR Newswire April 14, 2014

Abbott Completes Enrollment of Absorb(TM) Randomized Clinical Trials in the United States, Japan and China

PR Newswire April 10, 2014

Abbott Hosts Conference Call for First-Quarter Earnings

PR Newswire April 1, 2014

Abbott Announces FDA Approval of Its Supera® Stent to Treat People with Peripheral Artery Disease

PR Newswire March 28, 2014

Promising Biotechs Target New Ways to Kill Bad Bugs: Venture Capitalist Dennis Purcell

Equities.com March 19, 2014

Abbott Declares 361st Consecutive Quarterly Dividend

PR Newswire February 21, 2014

Five Star Equities Issues New Research Reports on ABT, ETR, USB and VLO

Accesswire January 24, 2014

Abbott Reports Fourth-Quarter and Full-Year 2013 Results

PR Newswire January 22, 2014

Wall Street Fundamentals Releases New In-Depth Stock Reports on ABT, BSX, MDT and STJ

Accesswire January 7, 2014

Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2013 Earnings

PR Newswire January 6, 2014

Abbott to Present at J.P. Morgan Healthcare Conference

PR Newswire December 19, 2013

A Space Age View into Human Vision: Abbott's iDesign Dx System Now Available for U.S. Ophthalmologists and Patients

PR Newswire December 17, 2013

Abbott Named Top Dealmaker for Sixth Consecutive Year by The Deal

PR Newswire November 18, 2013

Experience "A Day in the Life" of an Insulin-using Patient with Diabetes through Interactive Infographic

PR Newswire November 14, 2013

Abbott Supports Relief Efforts in the Philippines

PR Newswire November 13, 2013

Tiesto Teams Up with Music Saves Lives® and Abbott to Encourage Young People to Donate Blood

PR Newswire November 12, 2013

Partners In Health, Abbott and the Abbott Fund Open Nutrition Facility in Haiti

PR Newswire November 6, 2013

Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery

PR Newswire October 30, 2013

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

PR Newswire October 25, 2013